Overview

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
Patients will receive a single dose of 68Ga-PSMA-11 and undergo a PET/CT or PET/MRI imaging study.
Phase:
Phase 3
Details
Lead Sponsor:
University of Colorado, Denver